Estée Lauder Companies (EL) Competitors

Estée Lauder Companies (NYSE:EL) and Prestige Consumer Healthcare (NYSE:PBH) are both consumer staples companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, media sentiment, earnings, risk, profitability, community ranking, dividends, valuation and analyst recommendations.

Which has more risk & volatility, EL or PBH?

Estée Lauder Companies has a beta of 1.08, indicating that its stock price is 8% more volatile than the S&P 500. Comparatively, Prestige Consumer Healthcare has a beta of 0.46, indicating that its stock price is 54% less volatile than the S&P 500.

Is EL or PBH more profitable?

Prestige Consumer Healthcare has a net margin of 19.13% compared to Estée Lauder Companies' net margin of -4.61%. Estée Lauder Companies' return on equity of 16.82% beat Prestige Consumer Healthcare's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Estée Lauder Companies	-4.61%	16.82%	4.00%
Prestige Consumer Healthcare	19.13%	12.36%	6.39%

Does the media prefer EL or PBH?

In the previous week, Estée Lauder Companies had 8 more articles in the media than Prestige Consumer Healthcare. MarketBeat recorded 20 mentions for Estée Lauder Companies and 12 mentions for Prestige Consumer Healthcare. Estée Lauder Companies' average media sentiment score of 1.35 beat Prestige Consumer Healthcare's score of 1.00 indicating that Estée Lauder Companies is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Estée Lauder Companies	16 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	2 Very Negative mention(s)	Positive
Prestige Consumer Healthcare	7 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do institutionals & insiders hold more shares of EL or PBH?

55.2% of Estée Lauder Companies shares are owned by institutional investors. Comparatively, 99.9% of Prestige Consumer Healthcare shares are owned by institutional investors. 12.8% of Estée Lauder Companies shares are owned by company insiders. Comparatively, 1.6% of Prestige Consumer Healthcare shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Is EL or PBH a better dividend stock?

Estée Lauder Companies pays an annual dividend of $1.40 per share and has a dividend yield of 2.1%. Prestige Consumer Healthcare pays an annual dividend of $1.90 per share and has a dividend yield of 2.2%. Estée Lauder Companies pays out -71.8% of its earnings in the form of a dividend. Prestige Consumer Healthcare pays out 44.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

Does the MarketBeat Community prefer EL or PBH?

Estée Lauder Companies received 701 more outperform votes than Prestige Consumer Healthcare when rated by MarketBeat users. However, 70.35% of users gave Prestige Consumer Healthcare an outperform vote while only 67.97% of users gave Estée Lauder Companies an outperform vote.

Company	Underperform	Outperform
Estée Lauder Companies	Outperform Votes 1197 67.97%	Underperform Votes 564 32.03%
Prestige Consumer Healthcare	Outperform Votes 496 70.35%	Underperform Votes 209 29.65%

Which has stronger valuation and earnings, EL or PBH?

Estée Lauder Companies has higher revenue and earnings than Prestige Consumer Healthcare. Estée Lauder Companies is trading at a lower price-to-earnings ratio than Prestige Consumer Healthcare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Estée Lauder Companies	$15.18B	1.58	$390M	-$1.95	-34.27
Prestige Consumer Healthcare	$1.12B	3.75	$209.34M	$4.27	19.82

Do analysts rate EL or PBH?

Estée Lauder Companies currently has a consensus price target of $86.00, indicating a potential upside of 28.69%. Prestige Consumer Healthcare has a consensus price target of $93.33, indicating a potential upside of 10.29%. Given Estée Lauder Companies' higher possible upside, analysts clearly believe Estée Lauder Companies is more favorable than Prestige Consumer Healthcare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Estée Lauder Companies	0 Sell rating(s)	19 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.17
Prestige Consumer Healthcare	0 Sell rating(s)	3 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50

Summary

Estée Lauder Companies beats Prestige Consumer Healthcare on 11 of the 20 factors compared between the two stocks.